Zhang Chun-Lin, Ma Jing-Jie, Li Xiang, Yan Hai-Qing, Gui Yong-Kun, Yan Zhi-Xin, You Ming-Feng, Zhang Ping
Department of Neurology, The First Affiliated Hospital of Xinxiang Medical University, Xinxiang, China.
Department of Audit, The First Affiliated Hospital of Xinxiang Medical University, Xinxiang, China.
Front Pharmacol. 2025 Apr 16;16:1565382. doi: 10.3389/fphar.2025.1565382. eCollection 2025.
The blood-retina barrier (BRB) serves as a critical interface that separates the retina from the circulatory system, playing an essential role in preserving the homeostasis of the microenvironment within the retina. Specialized tight junctions and limited vesicle trafficking restrict paracellular and transcellular transport, respectively, thereby maintaining BRB barrier properties. Additionally, transcytosis of macromolecules through retinal vascular endothelial cells constitutes a primary mechanism for transporting substances from the vascular compartment into the surrounding tissue. This review summarizes the fundamental aspects of transcytosis including its function in the healthy retina, the biochemical properties of transcytosis, and the methodologies used to study this process. Furthermore, we discuss the current understanding of transcytosis in the context of pathological BRB breakdown and present recent findings that highlight significant advances in drug delivery to the retina based on transcytosis.
血视网膜屏障(BRB)是一个关键界面,将视网膜与循环系统分隔开,在维持视网膜内微环境的稳态方面发挥着重要作用。特化的紧密连接和有限的囊泡运输分别限制了细胞旁运输和跨细胞运输,从而维持BRB的屏障特性。此外,大分子通过视网膜血管内皮细胞的转胞吞作用是将物质从血管腔运输到周围组织的主要机制。本综述总结了转胞吞作用的基本方面,包括其在健康视网膜中的功能、转胞吞作用的生化特性以及用于研究该过程的方法。此外,我们在病理性BRB破坏的背景下讨论了对转胞吞作用的当前理解,并介绍了最近的研究结果,这些结果突出了基于转胞吞作用的视网膜药物递送的重大进展。